Gastric

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
40953
Randomized phase II study of weekly 24 h infusion of high dose 5-FU plus or minus Folinic Acid (HD-FU/FA) versus HD-FU/FA plus biweekly Cisplatin in advanced gastric cancer.
40902
Randomized phase III study of ELF (etoposide + 5-FU + Leucovorin) versus 5-FU continuous infusion + Cisplatin versus FAMTX (Methotrexate + 5-FU combined with adriamycin) in advanced gastric cancer
40905
Phase III trial of adjuvant chemotherapy with FAMTX in resectable gastric cancer
16864B
Phase II Chemotherapy with Flavone Acetic Acid in Patients with Advanced Gastric Cancer (Summary Last Modified 06/88)
16852
PHASE II TRIAL OF IPROPLATIN (CHIP,JM-9) IN PATIENTS WITH ADVANCED GASTRIC CARCINOMA .
40813
Adjuvant chemotherapy in resectable gastric cancer.
40954
Randomized phase III study of preoperative chemotherapy followed by surgery versus surgery alone in locally advanced gastric cancer (cT3 and cT4NxM0).
40906
Adjuvant intraoperative radiotherapy in gastric cancer.
40071
Effectiveness of first line treatment with lapatinib and ECF/X in histologically proven adenocarcinoma of the stomach or the esophagogastric junction, metastatic or not amenable to curative surgery according to HER2 and EGFR status: a randomized phase II trial.
62063
A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate.
20961
A phase II clinical trial of anti-helicobacter pylori treatment in endoscopically diagnosed low-grade localized gastric lymphoma
16921G
Phase II trial with Taxotere in patients with gastric aenocarcinoma
16901G
Phase II trial of Gemcitabine (LY 188011) in patients with gastric carcinoma

Back to Site-list